ArticleFrontiers in immunology2026
Comparative analysis of microbiota in the ocular surface of patients with atopic keratoconjunctivitis and Stevens-Johnson Syndrome with severe ocular complications.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The interplay between host immunity and the microbiome is increasingly recognized as an important factor in ocular surface diseases. Although cutaneous and intestinal dysbiosis have been implicated in atopic dermatitis (AD), the role of the ocular microbiome in its severe ophthalmic manifestation, atopic keratoconjunctivitis (AKC), remains incompletely understood. Methods: We performed 16S rRNA gene sequencing to characterize the ocular and fecal microbiota of patients with AD and severe AKC, AD without severe ocular involvement, Stevens-Johnson syndrome (SJS) with severe ocular complications (SOC), and healthy controls. Microbial community composition was compared using principal coordinate analysis (PCoA) and taxonomic profiling. Results: Ocular microbiota composition differed among the study groups. PCoA demonstrated that SJS samples clustered separately from healthy controls, whereas AKC samples occupied an intermediate position between the healthy control and SJS groups. Taxonomic analysis revealed enrichment of Corynebacterium 1 (a SILVA genus-level taxonomic assignment) in SJS, while AKC samples exhibited increased relative abundances of both Corynebacterium 1 and Staphylococcus. In contrast, AD patients without severe ocular involvement maintained an ocular microbial community broadly similar to that of healthy controls, including the presence of Neisseria. Analysis of paired fecal samples did not reveal disease-associated clustering or major compositional differences among the study groups. Discussion: These findings suggest that, using genus-level 16S rRNA sequencing, disease-associated microbial alterations are more readily detected on the ocular surface than in the fecal microbiome in this cohort. The results support a potential contribution of the local ocular microenvironment to microbial signatures associated with immune-mediated ocular surface inflammation and provide a framework for future studies investigating the role of the ocular microbiome in disease pathogenesis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.